ITMI20021684A1 - Composizione farmaceutica di peptide nasale - Google Patents

Composizione farmaceutica di peptide nasale

Info

Publication number
ITMI20021684A1
ITMI20021684A1 IT2002MI001684A ITMI20021684A ITMI20021684A1 IT MI20021684 A1 ITMI20021684 A1 IT MI20021684A1 IT 2002MI001684 A IT2002MI001684 A IT 2002MI001684A IT MI20021684 A ITMI20021684 A IT MI20021684A IT MI20021684 A1 ITMI20021684 A1 IT MI20021684A1
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
nasal peptide
nasal
peptide
pharmaceutical
Prior art date
Application number
IT2002MI001684A
Other languages
English (en)
Inventor
Paolo Alberto Veronesi
Pablo Eduardo Andres Rodriguez
Original Assignee
Therapicon Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapicon Srl filed Critical Therapicon Srl
Priority to IT2002MI001684A priority Critical patent/ITMI20021684A1/it
Priority to JP2004526696A priority patent/JP2006503005A/ja
Priority to EP03735674A priority patent/EP1524987A1/en
Priority to US10/516,613 priority patent/US20050158247A1/en
Priority to AU2003238039A priority patent/AU2003238039A1/en
Priority to PCT/EP2003/006641 priority patent/WO2004014411A1/en
Publication of ITMI20021684A1 publication Critical patent/ITMI20021684A1/it
Priority to US12/186,251 priority patent/US20090035260A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT2002MI001684A 2002-07-29 2002-07-29 Composizione farmaceutica di peptide nasale ITMI20021684A1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT2002MI001684A ITMI20021684A1 (it) 2002-07-29 2002-07-29 Composizione farmaceutica di peptide nasale
JP2004526696A JP2006503005A (ja) 2002-07-29 2003-06-24 経鼻ペプチド薬学的製剤
EP03735674A EP1524987A1 (en) 2002-07-29 2003-06-24 Nasal peptide pharmaceutical formulation
US10/516,613 US20050158247A1 (en) 2002-07-29 2003-06-24 Nasal peptide pharmaceutical formulation
AU2003238039A AU2003238039A1 (en) 2002-07-29 2003-06-24 Nasal peptide pharmaceutical formulation
PCT/EP2003/006641 WO2004014411A1 (en) 2002-07-29 2003-06-24 Nasal peptide pharmaceutical formulation
US12/186,251 US20090035260A1 (en) 2002-07-29 2008-08-05 Enhanced nasal composition of active peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001684A ITMI20021684A1 (it) 2002-07-29 2002-07-29 Composizione farmaceutica di peptide nasale

Publications (1)

Publication Number Publication Date
ITMI20021684A1 true ITMI20021684A1 (it) 2004-01-29

Family

ID=30130946

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI001684A ITMI20021684A1 (it) 2002-07-29 2002-07-29 Composizione farmaceutica di peptide nasale

Country Status (6)

Country Link
US (1) US20050158247A1 (it)
EP (1) EP1524987A1 (it)
JP (1) JP2006503005A (it)
AU (1) AU2003238039A1 (it)
IT (1) ITMI20021684A1 (it)
WO (1) WO2004014411A1 (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
CA2535156A1 (en) 2003-08-08 2005-02-24 Abgenix, Inc. Antibodies directed to parathyroid hormone (pth) and uses thereof
US7318925B2 (en) 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
US20050153946A1 (en) * 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
ES2692345T5 (es) * 2008-12-22 2024-01-26 Acerus Pharmaceuticals Usa Llc Administración intranasal de desmopresina
AU2015261630B2 (en) * 2008-12-22 2017-09-14 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
PL3679941T3 (pl) * 2009-06-18 2023-04-17 Serenity Pharmaceuticals Llc Bezpieczne podawanie desmopresyny
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US11679210B2 (en) * 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
JP2020526233A (ja) * 2017-06-28 2020-08-31 グレンマーク・スペシャルティー・エスエー 鼻炎の治療のための投与装置及び医薬組成物
US12303635B2 (en) 2018-04-16 2025-05-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN111544569A (zh) * 2020-05-13 2020-08-18 吉林吉力生物技术研究有限公司 一种动物注射用醋酸布舍瑞林冻干粉针剂及其制备方法和应用
US12214010B2 (en) 2023-04-04 2025-02-04 Tulex Pharmaceuticals Inc. Desmopressin oral compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0374120A3 (en) * 1988-12-13 1991-07-31 Monsanto Company Comosition for controlled release of polypeptides
KR0157428B1 (ko) * 1989-02-17 1998-11-16 알렌 불룸 비 전달용 지질부형제와 그 사용법
IT1243742B (it) * 1990-10-12 1994-06-21 Istituto Biochimico Nazionale Composizioni farmaceutiche a base di calcitonine
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
ZA984697B (en) * 1997-06-13 1999-12-01 Lilly Co Eli Stable insulin formulations.
ATE260674T1 (de) * 1998-08-17 2004-03-15 Pfizer Prod Inc Stabilisierte proteinzusammensetzung
AU2001220765A1 (en) * 2000-01-24 2001-07-31 Medtronic Minimed, Inc. Mixed buffer system for stabilizing polypeptide formulations

Also Published As

Publication number Publication date
WO2004014411A1 (en) 2004-02-19
AU2003238039A1 (en) 2004-02-25
JP2006503005A (ja) 2006-01-26
US20050158247A1 (en) 2005-07-21
EP1524987A1 (en) 2005-04-27

Similar Documents

Publication Publication Date Title
IS7714A (is) Lyfjasamsetningar úr módafíníl
KR20050009999A (ko) 약제학적 제제
FI20011478A0 (fi) Farmaseuttinen koostumus
PT1501534E (pt) Formulacoes farmaceuticas
ITMI20021684A1 (it) Composizione farmaceutica di peptide nasale
IS6986A (is) Lyfjasamsetning í vökvaformi
CY2018005I2 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
DE60103504D1 (de) Nasal verabreichbare cyclische antimykotische peptidzusammensetzungen
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
ATE309789T1 (de) Darreichungsform von ibuprofen-natrium
IS7051A (is) Lyfjasamsetningar
FI20022128L (fi) Farmaseuttinen koostumus
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
EP1578787A4 (en) NEW CHI-CONOTOXINPEPTIDES (-II)
NO20034556L (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
DK1474152T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende ivabradin
DK1467750T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende perindopril
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
ATE349213T1 (de) Nasale pharmazeutische zusammensetzung von piribedil
PT1467737E (pt) Composicao farmaceutica orodispersivel de piribedil
NO20044164L (no) Farmasoytiske sammensetninger
IL164756A0 (en) Pharmaceutical compositions containing protein pump inhibitors